Triplet Energy Transfer‐Sensitized NIR‐II Luminescent Nanoprobes for Ultrasensitive Detection of Prostate‐Specific Antigen
Aggregate · 2025-11 · 6 (11)
DOI: 10.1002/agt2.70178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aggregate, online erschienen am 12.10.2025. Verfasst von Hang Gao und 6 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
The ultrasensitive detection of prostate‐specific antigen (PSA) remains challenging for therapeutic evaluation and management of prostate cancer, particularly in monitoring post‐prostatectomy recurrence. Current immunoassays, however, lack the sensitivity and robustness necessary for detecting trace‐level PSA in clinical samples. To address this limitation, we develop a triplet energy transfer (TET)‐sensitized downshifting luminescence immunosorbent assay (TET‐DLISA) platform by utilizing size‐optimized NaGdF 4 :Yb 3+ /Er 3+ downshifting nanoparticles (DSNPs) functionalized with a carboxylated near‐infrared dye (Cypate) as signal reporters, for background‐free NIR‐II detection. Under 808‐nm excitation, efficient TET from Cypate to Yb 3+ amplifies the NIR‐II emission of Er 3+ by 284 times in 5.8‐nm DSNPs, achieving a highly enhanced intersystem crossing efficiency (82.8%) while minimizing interfacial energy loss. By introducing DSNP@Cypate as an NIR‐II signal reporter, the proposed TET‐DLISA enables ultrasensitive PSA quantification via alkaline phosphatase (ALP)‐catalyzed phosphate displacement of Cypate, yielding an outstanding signal‐to‐background ratio (SBR) of 273 and a detection limit of 98 fg mL −1 , which is three orders of magnitude more sensitive than the corresponding ALP‐based ELISA. Clinical validation with patient sera confirms a strong correlation with the results from commercial kits, demonstrating the platform's clinical utility for post‐surgical monitoring. This TET‐DLISA platform provides a transformative paradigm for ultrasensitive biomarker detection, addressing unmet needs in precision diagnostics.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Chinese Academy of Sciences
Zitieren
APA
Gao, H., Liu, Y., Liu, L., Li, R., Tu, D., Lin, Y., & Chen, X. (2025). Triplet Energy Transfer‐Sensitized NIR‐II Luminescent Nanoprobes for Ultrasensitive Detection of Prostate‐Specific Antigen. Aggregate, 6(11). https://doi.org/10.1002/agt2.70178
Vancouver
Gao H, Liu Y, Liu L, Li R, Tu D, Lin Y, et al. Triplet Energy Transfer‐Sensitized NIR‐II Luminescent Nanoprobes for Ultrasensitive Detection of Prostate‐Specific Antigen. Aggregate. 2025;6(11). doi:10.1002/agt2.70178
BibTeX
@article{Gao2025,
author = {Gao, Hang and Liu, Yan and Liu, Lijuan and Li, Renfu and Tu, Datao and Lin, Yao and Chen, Xueyuan},
title = {Triplet Energy Transfer‐Sensitized NIR‐II Luminescent Nanoprobes for Ultrasensitive Detection of Prostate‐Specific Antigen},
journal = {Aggregate},
year = {2025},
volume = {6},
number = {11},
doi = {10.1002/agt2.70178}
}
EUVIMED